Stigma Surrounding the Use of Medically Assisted Treatment for Opioid Use Disorder

References

• Allen, B., Nolan, M. L., & Paone, D. (2019). Underutilization of medications to treat opioid use disorder: What role does stigma play?Substance Abuse, 40(4), 459–465. https://doi.org/10.1080/08897077.2019.1640833
   PubMed Web of Science ®Google Scholar
• American Society of Addiction Medicine (ASAM) (2016). Opioid addiction: 2016 facts and figures [Internet]. https://www.asam.org/docs/default-source/advocacy/opioid-addiction-disease-facts-figures.pdf.
   Google Scholar
• Biancarelli, D. L., Biello, K. B., Childs, E., Drainoni, M., Salhaney, P., Edeza, A., Mimiaga, M. J., Saitz, R., & Bazzi, A. R. (2019). Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug and Alcohol Dependence, 198, 80–86. https://doi.org/10.1016/j.drugalcdep.2019.01.037
   PubMed Web of Science ®Google Scholar
• Boyd, S. J., Fan, L. J., Medoff, D. R., Dixon, L. B., & Gorelick, D. A. (2012). Use of a ‘microecological technique’ to study crime incidents around methadone maintenance treatment centers. Addiction, 107(9), 1632–1638. https://doi.org/10.1111/j.1360-0443.2012.03872.x
   PubMed Web of Science ®Google Scholar
• Brown, S. A. (2011). Standardized measures for substance use stigma. Drug and Alcohol Dependence, 116(1-3), 137–141. https://doi.org/10.1016/j.drugalcdep.2010.12.005
   PubMed Web of Science ®Google Scholar
• Brown, S. A., Kramer, K., Lewno, B., Dumas, L., Sacchetti, G., & Powell, E. (2015). Correlates of self-stigma among individuals with substance use problems. International Journal of Mental Health and Addiction, 13(6), 687–698. https://doi.org/10.1007/s11469-015-9559-9
   Web of Science ®Google Scholar
• Cama, E., Brener, L., Wilson, H., & von Hippel, C. (2016). Internalized stigma among people who inject drugs. Substance Use & Misuse, 51(12), 1664–1668. https://doi.org/10.1080/10826084.2016.1188951
   PubMed Web of Science ®Google Scholar
• Can, G., & Tanrıverdi, D. (2015). Social functioning and internalized stigma in individuals diagnosed with substance use disorder. Archives of Psychiatric Nursing, 29(6), 441–446. https://doi.org/10.1016/j.apnu.2015.07.008
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC) (2017).. Drug overdose deaths in the United States continue to increase in 2015 [Internet]. Retrieved December 11, 2017, from https://www.cdc.gov/drugoverdose/epidemic/index.html.
   Google Scholar
• Cerully, J. L., Acosta, J. D., & Sloan, J. (2018). Mental health stigma and its effects on treatment-related outcomes: A narrative review. Military Medicine, 183(11-12), e427–e437. https://doi.org/10.1093/milmed/usx219
   PubMed Web of Science ®Google Scholar
• Chan, J. Y. N., Mak, W. W. S., & Law, L. S. C. (2009). Combining education and video-based contact to reduce stigma of mental illness: “The Same or Not the Same” anti-stigma program for secondary schools in Hong Kong. Social Science & Medicine, 68(8), 1521–1526. https://doi.org/10.1016/j.socscimed.2009.02.016
   PubMed Web of Science ®Google Scholar
• Corrigan, P. W. (2000). Mental health stigma as social attribution: Implications for research methods and attitude change. Clinical Psychology: Science and Practice, 7(1), 48–67. https://doi.org/10.1093/clipsy.7.1.48
   Web of Science ®Google Scholar
• Corrigan, P. W., Qin, S., Davidson, L., Schomerus, G., Shuman, V., & Smelson, D. (2020). Recovery from mental illness versus substance use disorder. Advances in Dual Diagnosis, 13(3), 101–110. https://doi.org/10.1108/ADD-10-2019-0012
   Web of Science ®Google Scholar
• Corrigan, P. W., Schomerus, G., Shuman, V., Kraus, D., Perlick, D., Harnish, A., Kulesza, M., Kane, W. K., Qin, S., & Smelson, D. (2017). Developing a research agenda for reducing the stigma of addictions, part II: Lessons from the mental health stigma literature. The American Journal on Addictions, 26(1), 67–74. https://doi.org/10.1111/ajad.12436
   PubMed Web of Science ®Google Scholar
• Earnshaw, V. A., Smith, L. R., Chaudoir, S. R., Amico, K. R., & Copenhaver, M. M. (2013). HIV stigma mechanisms and well-being among PLWH: A test of the HIV stigma framework. AIDS and Behavior, 17(5), 1785–1795. https://doi.org/10.1007/s10461-013-0437-9
   PubMed Web of Science ®Google Scholar
• Earnshaw, V. A., Smith, L. R., & Copenhaver, M. M. (2013). Drug addiction stigma in the context of methadone maintenance therapy: An investigation into understudied sources of stigma. International Journal of Mental Health and Addiction, 11(1), 110–122. https://doi.org/10.1007/s11469-012-9402-5
   PubMed Web of Science ®Google Scholar
• Etesam, F., Assarian, F., Hosseini, H., & Ghoreishi, F. S. (2014). Stigma and its determinants among male drug dependents receiving methadone maintenance treatment. Archives of Iranian Medicine, 17(2), 108–114.
   PubMed Web of Science ®Google Scholar
• Finkelstein, J., Lapshin, O., & Wasserman, E. (2008). Randomized study of different anti-stigma media. Patient Education and Counseling, 2, 204.
   Google Scholar
• Fullerton, C. A., Kim, M., Thomas, C. P., Lyman, D. R., Montejano, L. B., Dougherty, R. H., Daniels, A. S., Ghose, S. S., & Delphin-Rittmon, M. E. (2014). Medication-assisted treatment with methadone: Assessing the evidence. Psychiatric Services (Washington, D.C.), 65(2), 146–157. https://doi.org/10.1176/appi.ps.201300235
   PubMed Web of Science ®Google Scholar
• Hatzenbuehler, M. L., Phelan, J. C., & Link, B. G. (2013). Stigma as a fundamental cause of population health inequalities. American Journal of Public Health, 103(5), 813–821. https://doi.org/10.2105/AJPH.2012.301069
   PubMed Web of Science ®Google Scholar
• Jones, C. M., & McCance-Katz, E. F. (2019). Co-occurring substance use and mental disorders among adults with opioid use disorder. Drug and Alcohol Dependence, 197, 78–82. https://doi.org/10.1016/j.drugalcdep.2018.12.030
   PubMed Web of Science ®Google Scholar
• Karki, P., Shrestha, R., Huedo-Medina, T. B., & Copenhaver, M. (2016). The impact of methadone maintenance treatment on HIV risk behaviors among high-risk injection drug users: A systematic review. Evidence-Based Medicine and Public Health, 2, e1229.
   PubMedGoogle Scholar
• Kelleher, C. (2009). Minority stress and health: Implications for lesbian, gay, bisexual, transgender, and questioning (LGBTQ) young people. Counselling Psychology Quarterly, 22(4), 373–379. https://doi.org/10.1080/09515070903334995
   Google Scholar
• Kulesza, M., Watkins, K. E., Ober, A. J., Osilla, K. C., & Ewing, B. (2017). Internalized stigma as an independent risk factor for substance use problems among primary care patients: Rationale and preliminary support. Drug and Alcohol Dependence, 180, 52–55. https://doi.org/10.1016/j.drugalcdep.2017.08.002
   PubMed Web of Science ®Google Scholar
• Link, B. G., & Phelan, J. C. (2001). Conceptualizing stigma. Annual Review of Sociology, 27(1), 363–385. https://doi.org/10.1146/annurev.soc.27.1.363
   Web of Science ®Google Scholar
• Link, B. G., Yang, L. H., Phelan, J. C., & Collins, P. Y. (2004). Measuring mental illness stigma. Schizophrenia Bulletin, 30(3), 511–541. https://doi.org/10.1093/oxfordjournals.schbul.a007098
   PubMed Web of Science ®Google Scholar
• Livingston, J. D., Milne, T., Fang, M. L., & Amari, E. (2012). The effectiveness of interventions for reducing stigma related to substance use disorders: A systematic review. Addiction (Abingdon, England), 107(1), 39–50. https://doi.org/10.1111/j.1360-0443.2011.03601.x
   PubMed Web of Science ®Google Scholar
• Lloyd, C. (2013). The stigmatization of problem drug users: A narrative literature review. Drugs: Education, Prevention and Policy, 20(2), 85–95.
   Web of Science ®Google Scholar
• Lobmaier, P., Gossop, M., Waal, H., & Bramness, J. (2010). The pharmacological treatment of opioid addiction—A clinical perspective. European Journal of Clinical Pharmacology, 66(6), 537–545. https://doi.org/10.1007/s00228-010-0793-6
   PubMed Web of Science ®Google Scholar
• Luoma, J. B., Kulesza, M., Hayes, S. C., Kohlenberg, B., & Larimer, M. (2014). Stigma predicts residential treatment length for substance use disorder. The American Journal of Drug and Alcohol Abuse, 40(3), 206–212. https://doi.org/10.3109/00952990.2014.901337
   PubMed Web of Science ®Google Scholar
• Ma, J., Bao, Y.-P., Wang, R.-J., Su, M.-F., Liu, M.-X., Li, J.-Q., Degenhardt, L., Farrell, M., Blow, F. C., Ilgen, M., Shi, J., & Lu, L. (2019). Effects of medication-assisted treatment on mortality among opioids users: A systematic review and meta-analysis. Molecular Psychiatry, 24(12), 1868–1883. https://doi.org/10.1038/s41380-018-0094-5
   PubMed Web of Science ®Google Scholar
• Matthews, S., Dwyer, R., & Snoek, A. (2017). Stigma and self-stigma in addiction. Journal of Bioethical Inquiry, 14(2), 275–286. https://doi.org/10.1007/s11673-017-9784-y
   PubMed Web of Science ®Google Scholar
• McElrath, K. (2018). Medication-assisted treatment for opioid addiction in the United States: Critique and commentary. Substance Use & Misuse, 53(2), 334–343. https://doi.org/10.1080/10826084.2017.1342662
   PubMed Web of Science ®Google Scholar
• McPhee, I., Brown, A., & Martin, C. (2013). Stigma and perceptions of recovery in Scotland: A qualitative study of injecting drug users attending methadone treatment. Drugs and Alcohol Today, 13(4), 244–257. https://doi.org/10.1108/DAT-05-2013-0022
   Google Scholar
• Molero, Y., Zetterqvist, J., Binswanger, I. A., Hellner, C., Larsson, H., & Fazel, S. (2018). Medications for alcohol and opioid use disorders and risk of suicidal behavior, accidental overdoses, and crime. The American Journal of Psychiatry, 175(10), 970–978. https://doi.org/10.1176/appi.ajp.2018.17101112
   PubMed Web of Science ®Google Scholar
• National Academies of Sciences, Engineering, and Medicine (NASEM). (2017). Pain management and the opioid epidemic: Balancing societal and individual benefits and risks of prescription opioid use. National Academies Press.
   Google Scholar
• National Academies of Sciences, Engineering, and Medicine (NASEM) (2019). Medications for opioid use disorder save lives [Internet]. https://www.nap.edu/catalog/25310/medications-for-opioid-use-disorder-save-lives
   Google Scholar
• National Institute on Drug Abuse (2019). Drug facts: National trends 2016 [Internet]. http://www.drugabuse.gov/publications/drugfacts/nationwide-trends.
   Google Scholar
• National Institute on Drug Abuse (2019). Opioid overdose crisis [Internet]. https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis
   Google Scholar
• Norman, R. M. G., Gawronski, B., Hampson, E., Sorrentino, R. M., Szeto, A., & Ye, Y. (2010). Physical proximity in anticipation of meeting someone with schizophrenia: The role of explicit evaluations, implicit evaluations and cortisol levels. Schizophrenia Research, 124(1–3), 74–80. https://doi.org/10.1016/j.schres.2010.07.021
   PubMed Web of Science ®Google Scholar
• Olsen, Y., & Sharfstein, J. M. (2014). Confronting the stigma of opioid use disorder-and its treatment. JAMA, 311(14), 1393–1394. https://doi.org/10.1001/jama.2014.2147
   PubMed Web of Science ®Google Scholar
• Paquette, C. E., Syvertsen, J. L., & Pollini, R. A. (2018). Stigma at every turn: Health services experiences among people who inject drugs. The International Journal on Drug Policy, 57, 104–110. https://doi.org/10.1016/j.drugpo.2018.04.004
   PubMed Web of Science ®Google Scholar
• Pinfold, V., Thornicroft, G., Huxley, P., & Farmer, P. (2005). Active ingredients in anti-stigma programmes in mental health. International Review of Psychiatry (Abingdon, England), 17(2), 123–131. https://doi.org/10.1080/09540260500073638
   PubMed Web of Science ®Google Scholar
• Rintamaki, L., Kosenko, K., Hogan, T., Scott, A. M., Dobmeier, C., Tingue, E., & Peek, D. (2019). The role of stigma management in HIV treatment adherence. International Journal of Environmental Research and Public Health, 16(24), 5003.
   PubMed Web of Science ®Google Scholar
• Rivera, A. V., DeCuir, J., Crawford, N. D., Amesty, S., & Lewis, C. F. (2014). Internalized stigma and sterile syringe use among people who inject drugs in New York City, 2010–2012. Drug and Alcohol Dependence, 144, 259–264. https://doi.org/10.1016/j.drugalcdep.2014.09.778
   PubMed Web of Science ®Google Scholar
• Saxon, A. J., Hser, Y. I., Woody, G., & Ling, W. (2013). Medication-assisted treatment for opioid addiction: Methadone and buprenorphine. Journal of Food and Drug Analysis, 21(4), S69–S72. https://doi.org/10.1016/j.jfda.2013.09.037
   PubMedGoogle Scholar
• Schulze, B., Richter, W. M., Matschinger, H., & Angermeyer, M. C. (2003). Crazy? So what! Effects of a school project on students’ attitudes towards people with schizophrenia. Acta Psychiatrica Scandinavica, 107(2), 142–150. https://doi.org/10.1034/j.1600-0447.2003.02444.x
   PubMed Web of Science ®Google Scholar
• Shidlansik, L., Adelson, M., & Peles, E. (2017). Knowledge and stigma regarding methadone maintenance treatment among personnel of methadone maintenance treatment and non-methadone maintenance treatment addiction facilities in Israel. Journal of Addictive Diseases, 36(1), 30–37. https://doi.org/10.1080/10550887.2016.1235404
   PubMed Web of Science ®Google Scholar
• Tran, B. X., Vu, P. B., Nguyen, L. H., Latkin, S. K., Nguyen, C. T., Phan, H. T., & Latkin, C. A. (2016). Drug addiction stigma in relation to methadone maintenance treatment by different service delivery models in Vietnam. BMC Public Health, 16(1), 238. https://doi.org/10.1186/s12889-016-2897-0
   PubMedGoogle Scholar
• Tran, T. H., Griffin, B. L., Stone, R. H., Vest, K. M., & Todd, T. J. (2017). Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 37(7), 824. https://doi-org.libdata.lib.ua.edu/10.1002/phar.1958
   Google Scholar
• Valery, K.-M., & Prouteau, A. (2020). Schizophrenia stigma in mental health professionals and associated factors: A systematic review. Psychiatry Research, 290, 113068. https://doi.org/10.1016/j.psychres.2020.113068
   PubMed Web of Science ®Google Scholar
• Van Boekel, L. C., Brouwers, E. P., Van Weeghel, J., & Garretsen, H. F. (2013). Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: Systematic review. Drug and Alcohol Dependence, 131(1–2), 23–35. https://doi.org/10.1016/j.drugalcdep.2013.02.018
   PubMed Web of Science ®Google Scholar
• Van Nguyen, H., Nguyen, H. L., Mai, H. T., Le, H. Q., Tran, B. X., Hoang, C. D., Le, H. T., Nguyen, C. T., Tran, T. D., Latkin, C. A., & Vu, T. M. (2017). Stigmatization among methadone maintenance treatment patients in mountainous areas in northern Vietnam. Harm Reduction Journal, 14(1), 1–7. https://doi.org/10.1186/s12954-016-0127-9
   PubMedGoogle Scholar
• Volkow, N. D., & Koob, G. (2015). Brain disease model of addiction: Why is it so controversial?The Lancet Psychiatry, 2(8), 677–679. https://doi.org/10.1016/S2215-0366(15)00236-9
   PubMed Web of Science ®Google Scholar
• Wakeman, S. E. (2017). Medications for addiction treatment: Changing language to improve care. Journal of Addiction Medicine, 11(1), 1–2. https://doi.org/10.1097/ADM.0000000000000275
   PubMed Web of Science ®Google Scholar
• Wakeman, S. E., & Rich, J. D. (2018). Barriers to medications for addiction treatment: How stigma kills. Substance Use & Misuse, 53(2), 330–333. https://doi.org/10.1080/10826084.2017.1363238
   PubMed Web of Science ®Google Scholar
• Witte, T. H., Wright, A., & Stinson, E. A. (2019). Factors influencing stigma toward individuals who have substance use disorders. Substance Use & Misuse, 54(7), 1115–1124. https://doi.org/10.1080/10826084.2018.1560469
   PubMed Web of Science ®Google Scholar
• Woo, J., Bhalerao, A., Bawor, M., Bhatt, M., Dennis, B., Mouravska, N., Zielinski, L., & Samaan, Z. (2017). Don’t judge a book by its cover”: A qualitative study of methadone patients’ experiences of stigma. Journal of Substance Abuse Treatment, 111, 1-12.
   Google Scholar
• Yang, L., Wong, L. Y., Grivel, M. M., & Hasin, D. S. (2017). Stigma and substance use disorders: An international phenomenon. Current Opinion in Psychiatry, 30(5), 378–388. https://doi.org/10.1097/YCO.0000000000000351
   PubMed Web of Science ®Google Scholar
• Zibbell, J. E., Asher, A. K., Patel, R. C., Kupronis, B., Iqbal, K., Ward, J. W., & Holtzman, D. (2018). Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014. American Journal of Public Health, 108(2), 175–181. https://doi.org/10.2105/AJPH.2017.304132
   PubMed Web of Science ®Google Scholar